The Board resolution dated May 19, 2021, the BOD of Imexpharm Corporation approved the following issues:
1) Approving the business result in Quarter 1/2021:
|
No.
|
Content
|
Q1/2021
|
% plan for 2021
|
Q2/2021
|
%Growth
|
|
1
|
Total revenue
|
301.1
|
19.7%
|
304.3
|
-1.1%
|
|
2
|
Net revenue
|
296.4
|
|
303.7
|
-2.4%
|
|
3
|
Profit before tax
|
55.2
|
19%
|
51.4
|
7.4%
|
|
4
|
Profit after tax
|
41.8
|
|
41.1
|
1.7%
|
2) Approving the business plan in Quarter 2/2021:
- Total revenue: 364.0 billion dongs
- Profit before tax: 75.4 billion dongs.
3) Approving the record date to cash dividend for 2020:
- Record date: June 24, 2021
- Exercise ratio: 15% (1,500 dongs/share)
- Payment date: July 16, 2021.
4) Approving the company will not withdraw 30,000 ESOP shares from Mr. Nguyen Vu Quoc Trung that he resigned.